Fernando

Dr. Julio Montaner receives King Charles III Coronation Medal

August 31st is International Overdose Awareness Day, an annual campaign to end overdoses, remember without stigma those who have died from overdose, and acknowledge the grief of the family and friends left behind. The BC Centre for Excellence in HIV/AIDS (BC-CfE) joins families, friends and communities in mourning the needless losses of life through overdose and continue to advocate for an end to the toxic drug crisis through a safer supply of drugs.

Dr. Julio Montaner receives King Charles III Coronation Medal Read More »

Recognizing those who go unseen – the impacts of fatal and non-fatal overdoses

August 31st is International Overdose Awareness Day, an annual campaign to end overdoses, remember without stigma those who have died from overdose, and acknowledge the grief of the family and friends left behind. The BC Centre for Excellence in HIV/AIDS (BC-CfE) joins families, friends and communities in mourning the needless losses of life through overdose and continue to advocate for an end to the toxic drug crisis through a safer supply of drugs.

Recognizing those who go unseen – the impacts of fatal and non-fatal overdoses Read More »

BC-CfE Executive Director Dr. Julio Montaner awarded 2023 CIHR-IPPH Trailblazer Award

The BC-CfE is proud to announce Executive Director & Physician-in-Chief Dr. Julio Montaner is among the three 2023 Canadian Institutes of Health Research Institute of Population and Public Health (CIHR-IPPH) Trailblazer Award Winners. Announced at the Canadian Public Health Association Conference, the Trailblazer Awards support early, mid and senior career researchers who have made exceptional contributions to population and public health in Canada and around the world through evidence-based policies and interventions.

BC-CfE Executive Director Dr. Julio Montaner awarded 2023 CIHR-IPPH Trailblazer Award Read More »

World AIDS Day 2022 message from Dr. Julio Montaner

This World AIDS Day, BC-CfE Executive Director & Physician-in-Chief Dr. Julio Montaner reflects on the immeasurable loss experienced due to HIV/AIDS and the challenges the disease has posed over the past 40 years. With the UNAIDS theme of ‘Equalize’, Dr. Montaner calls for leadership and funding at a national level to implement a national strategy based on Treatment as Prevention¨ to ensure provinces have the resources and framework to meet the ambitious 95-95-95 Targets.

World AIDS Day 2022 message from Dr. Julio Montaner Read More »

Dr. Paula Braitstein

The BC-CfE is saddened to learn of the passing of Dr. Paula Braitstein, a world-renowned expert in public health and epidemiology. She conducted numerous research studies across the globe, mentored countless students and was an ardent advocate for healthcare equity. Born in Montreal, Dr. Braitstein completed her graduate studies at the University of British Columbia under BC-CfE Senior Research Scientist Dr. Robert Hogg and was a dedicated research associate with the BC-CfE from 2000-2005.

Dr. Paula Braitstein Read More »

Montreal hosts the 24th International AIDS Conference

For the first time since BC-CfE Executive Director & Physician-in-Chief Dr. Julio Montaner welcomed the world to Vancouver in 2015, the International AIDS Society returned to Canada July 29th, bringing the 24th International AIDS Conference to Montreal (AIDS 2022). The world’s foremost meeting on HIV research, advocacy and policy-making, the biannual conference is the largest global gathering on any health issue in the world.

Montreal hosts the 24th International AIDS Conference Read More »

Antiretroviral drug interactions decline, but clinical screening for drug interactions remains important

New BC-CfE research, published in the recent issue of AIDS, characterizes trends in the annual prevalence of drug interactions between antiretroviral therapy (ART) and other non-antiretroviral medications in relation to ART prescribing patterns. The study also describes drug interaction-related ART changes.

Antiretroviral drug interactions decline, but clinical screening for drug interactions remains important Read More »

Scroll to Top